|
US2018067119A1
|
|
Compositions, methods and kits for diagnosis of lung cancer
|
|
US2017269090A1
|
|
Compositions, methods and kits for diagnosis of lung cancer
|
|
US2017184596A1
|
|
Organ Specific Diagnostic Panels and Methods for Identification of Organ Specific Panel Proteins
|
|
US2015219666A1
|
|
Integrated quantification method for protein measurements in clinical proteomics
|
|
WO2015042454A1
|
|
Compositions, methods and kits for diagnosis of lung cancer
|
|
WO2015013654A1
|
|
Compositions, methods and kits for diagnosis of lung cancer
|
|
WO2014100717A2
|
|
Compositions, methods and kits for diagnosis of lung cancer
|
|
US2015168421A1
|
|
Srm methods in alzheimer's disease and neurological disease assays
|
|
US2013230877A1
|
|
Compositions, methods and kits for diagnosis of lung cancer
|
|
WO2013096862A2
|
|
Selected reaction monitoring assays
|
|
WO2013096845A2
|
|
Methods for diagnosis of lung cancer
|
|
WO2013009869A2
|
|
Akt-specific capture agents, compositions, and methods of using and making
|
|
WO2012075042A1
|
|
Diagnostic lung cancer panel and methods for its use
|
|
WO2012075043A1
|
|
Alzheimer's disease diagnostic panels and methods for their use
|
|
US2010190656A1
|
|
Breast Cancer Specific Markers and Methods of Use
|
